The Department of Defense Neurofibromatosis (NF) Research Program recently awarded Drs. Joshua Breunig (Cedars Sinai), David Gutmann (Washington University), and Yuan Pan (MD Anderson Cancer Center) a three-year grant to study NF1-associated brain tumors. The team will leverage a state-of-the-art genetic technology called Mosaic Analysis with Dual Recombinases (MDAR) to model brain tumors in NF1 and study the neuro-immune-cancer crosstalk. This project will provide insights into risk factors that drive brain tumor pathogenesis in NF1, and into therapeutic options for affected individuals.
Josh Breunig, David Gutmann, and Yuan Pan receive a Collaborative Department of Defense Grant
